397 related articles for article (PubMed ID: 23007558)
1. Cellular and molecular mechanisms of hepatocellular carcinoma: an update.
Aravalli RN; Cressman EN; Steer CJ
Arch Toxicol; 2013 Feb; 87(2):227-47. PubMed ID: 23007558
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of hepatocellular carcinoma.
Aravalli RN; Steer CJ; Cressman EN
Hepatology; 2008 Dec; 48(6):2047-63. PubMed ID: 19003900
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.
Marquardt JU; Galle PR; Teufel A
J Hepatol; 2012 Jan; 56(1):267-75. PubMed ID: 21782758
[TBL] [Abstract][Full Text] [Related]
4. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.
Park JR; Kim RJ; Lee YK; Kim SR; Roh KJ; Oh SH; Kong G; Kang KS; Nam JS
J Hepatol; 2011 Jan; 54(1):122-31. PubMed ID: 20952084
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
6. Stellate cells and the development of liver cancer: therapeutic potential of targeting the stroma.
Coulouarn C; Clément B
J Hepatol; 2014 Jun; 60(6):1306-9. PubMed ID: 24530649
[TBL] [Abstract][Full Text] [Related]
7. Involvement of inflammation and its related microRNAs in hepatocellular carcinoma.
Jin K; Li T; Sánchez-Duffhues G; Zhou F; Zhang L
Oncotarget; 2017 Mar; 8(13):22145-22165. PubMed ID: 27888618
[TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
9. The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy.
Sukowati CH; Tiribelli C
Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):749-57. PubMed ID: 24161136
[TBL] [Abstract][Full Text] [Related]
10. Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma.
Lee TK; Cheung VC; Ng IO
Cancer Lett; 2013 Sep; 338(1):101-9. PubMed ID: 22579789
[TBL] [Abstract][Full Text] [Related]
11. Human hepatocellular carcinoma: expression profiles-based molecular interpretations and clinical applications.
Hui KM
Cancer Lett; 2009 Dec; 286(1):96-102. PubMed ID: 19095350
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA and hepatocellular carcinoma: biology and prognostic significance.
Milazzo M; Fornari F; Gramantieri L
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):257-71. PubMed ID: 21769076
[TBL] [Abstract][Full Text] [Related]
13. [Hepatocellular carcinoma: novel molecular aspects for differential diagnosis and therapy].
Kern MA; Schirmacher P
Verh Dtsch Ges Pathol; 2006; 90():85-98. PubMed ID: 17867584
[TBL] [Abstract][Full Text] [Related]
14. Biology of hepatic cancer stem cells.
Tong CM; Ma S; Guan XY
J Gastroenterol Hepatol; 2011 Aug; 26(8):1229-37. PubMed ID: 21557770
[TBL] [Abstract][Full Text] [Related]
15. [Novel therapeutic strategies for treatment of hepatocellular carcinoma: targeting intervention on liver cancer stem cells].
Li X; Luo Q; Song G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):894-8. PubMed ID: 24059077
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia inducible factors in hepatocellular carcinoma.
Chen C; Lou T
Oncotarget; 2017 Jul; 8(28):46691-46703. PubMed ID: 28493839
[TBL] [Abstract][Full Text] [Related]
17. [microRNA: new diagnostic and therapeutic tools in liver disease?].
Gougelet A; Colnot S
Med Sci (Paris); 2013 Oct; 29(10):861-7. PubMed ID: 24148124
[TBL] [Abstract][Full Text] [Related]
18. Role of the microenvironment in hepatocellular carcinoma development and progression.
Wu SD; Ma YS; Fang Y; Liu LL; Fu D; Shen XZ
Cancer Treat Rev; 2012 May; 38(3):218-25. PubMed ID: 21763074
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.
Chiba T; Kamiya A; Yokosuka O; Iwama A
Cancer Lett; 2009 Dec; 286(2):145-53. PubMed ID: 19464789
[TBL] [Abstract][Full Text] [Related]
20. Opportunities for targeted therapies in hepatocellular carcinoma.
Thomas MB; Abbruzzese JL
J Clin Oncol; 2005 Nov; 23(31):8093-108. PubMed ID: 16258107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
